CSMS #55671393

Food and Drug Administration (FDA) New Center for Drug Evaluation and Research (CDER) Product Codes

· View this week in context on the trade timeline

PGA UpdateLow urgency
Share this messageLinkedInEmail
CSMS # 55671393 - Food and Drug Administration (FDA) New Center for Drug Evaluation and Research (CDER) Product Codes U.S. Customs and Border Protection sent this bulletin at 03/28/2023 10:08 AM EDT CSMS # 55671393 - Food and Drug Administration (FDA) New Center for Drug Evaluation and Research (CDER) Product Codes The Food and Drug Administration (FDA) has created new Center for Drug Evaluation and Research (CDER) product codes listed below. They are available immediately. Product Code/Description 60M[][]30/Tapentadol (Analgesic, Narcotic) 61F[][]64/Daptomycin (Anti-Bacterial) (Not Antibiotic) 62V[][]86/Sofosbuvir (Anti-Viral) 62V[][]87/Ledipasvir (Anti-Viral) 62V[][]88/Cabotegravir (Anti-Viral) 62V[][]89/Elbasvir (Anti-Viral) 62V[][]90/Glecaprevir (Anti-Viral) Please send any questions or concerns to the email address for the Product Code Builder Feedback: PCBFeedback@fda.hhs.gov For assistance with product code identification, the public may also refer to the FDA Product Code Builder .
Agencies affected
FDA

This week in context

This message came out the week of March 25 to March 31, 2023. See that week against the 90 days before it, with every CSMS message by subject and the trade actions behind them.

Trade timeline preview: the week of March 25 to March 31, 2023 highlighted against the 90 days beforeView this week in context on the trade timeline →